[{"id":"1d901aad-6b7a-454e-9a35-cb2af530433a","acronym":"","url":"https://clinicaltrials.gov/study/NCT04006301","created_at":"2021-01-18T19:41:14.893Z","updated_at":"2024-07-02T16:36:38.986Z","phase":"Phase 1","brief_title":"First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation","source_id_and_acronym":"NCT04006301","lead_sponsor":"Janssen Research \u0026 Development, LLC","biomarkers":" KRAS","pipe":" | ","alterations":" KRAS G12C • KRAS G12","tags":["KRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS G12C • KRAS G12"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e JNJ-74699157"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 07/26/2019","start_date":" 07/26/2019","primary_txt":" Primary completion: 07/13/2020","primary_completion_date":" 07/13/2020","study_txt":" Completion: 07/13/2020","study_completion_date":" 07/13/2020","last_update_posted":"2020-11-06"}]